| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Canadian Journal of Anesthesia, Vol 39, 949-962, Copyright © 1992 by Canadian Anesthesiologists' Society
ARTICLES |
MD Sharpe
W.E. Spoerel Intensive Care Unit, University Hospital, Department of Anaesthesia, University of Western Ontario, London.
Neuromuscular blocking agents are frequently used in the Intensive Care Unit to facilitate tracheal intubation and the application of continuous paralysis. This review will focus on various conditions of the critically ill patient such as multi-organ dysfunction, acid-base and electrolyte imbalance, prolonged immobility, multiple drug interactions and specific disease/injury processes that may affect the pharmacokinetic and pharmacodynamic behaviour of muscle relaxants. As such, due to the complex nature of the critically ill patients, the effects of neuromuscular blocking agents are unpredictable. Therefore, guidelines regarding their administration and the methodology and requirement for continuous bedside monitoring of neuromuscular function will be presented.
This article has been cited by other articles:
![]() |
S. Tripathi and J. Hunter Neuromuscular blocking drugs in the critically ill CEACCP, June 1, 2006; 6(3): 119 - 123. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |